- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: her2 positive non operable breast cancer
Total 129133 results
-
The Netherlands Cancer InstituteAstraZeneca; Daiichi SankyoRecruiting
-
Henan Cancer HospitalRecruitingBreast Cancer | HER2-positive Breast CancerChina
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruitingHER2-positive Breast CancerChina
-
Institut de cancérologie Strasbourg EuropeNot yet recruitingProtocol for Herceptin as Adjuvant Therapy With Reduced Exposure to Chemotherapy (PHARE-C) (PHARE-C)HER2-positive Breast Cancer
-
Peking UniversityRecruitingHER2-positive Breast CancerChina
-
University of Alabama at BirminghamRecruitingHER2-positive Breast CancerUnited States
-
King's College LondonGuy's and St Thomas' NHS Foundation Trust; Brighton and Sussex University Hospitals...Recruiting
-
xuexin heNot yet recruitingHER2-positive Breast Cancer
-
University of Texas Southwestern Medical CenterMerck Sharp & Dohme LLC; Breast Cancer Research FoundationActive, not recruitingBreast Cancer | HER2-positive Breast CancerUnited States
-
Seagen Inc.Active, not recruitingHER2 Positive Breast CancerUnited States
-
Fox Chase Cancer CenterGenentech, Inc.Active, not recruitingHER2-positive Breast CancerUnited States
-
Zhejiang Hisun Pharmaceutical Co. Ltd.Completed
-
Fondazione Policlinico Universitario Agostino Gemelli...Active, not recruiting
-
Alteogen, Inc.CompletedHER2-positive Breast CancerKorea, Republic of
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingHER2-positive Breast CancerChina
-
Biyun Wang, MDCompleted
-
Guangdong Provincial People's HospitalCompletedHER2-Positive Breast CancerChina
-
Sun Yat-sen UniversityCompletedHER2 Positive Breast CancerChina
-
Guangdong Provincial People's HospitalUnknownHER2-Positive Breast CancerChina
-
Anhui Provincial HospitalUnknownHER2 Positive Breast Carcinoma
-
Shandong UniversityUnknownHER2-positive Breast Cancer
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedRecurrent Uterine Corpus Carcinoma | Endometrial Adenocarcinoma | Stage III Uterine Corpus Cancer AJCC v7 | Stage IV Uterine Corpus Cancer AJCC v7 | ERBB2 Gene AmplificationUnited States
-
National Cancer Institute (NCI)WithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic HER2-Negative Breast Carcinoma | Unresectable HER2-Negative Breast Carcinoma
-
Chongqing University Cancer HospitalNot yet recruitingCervical Cancer | Ovarian Cancer | Endometrial Cancer | HER2 Expression
-
Krankenhaus NordwestTerminatedHer2/Neu Positive Advanced Solid TumorsGermany
-
Samsung Medical CenterRecruitingHER2-positive Breast CancerKorea, Republic of
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Huashan HospitalRecruitingHER2-positive Breast CancerChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingA Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BCHER2-positive Breast CancerChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Cancer Trials IrelandRecruitingHER2-positive Breast CancerIreland
-
Institut de cancérologie Strasbourg EuropeNot yet recruitingHER2-positive Breast Cancer
-
Shengjing HospitalJiangsu HengRui Medicine Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
German Breast GroupRoche Pharma AGRecruitingHER2-positive Breast CancerGermany
-
iOMEDICO AGSeagen Inc.RecruitingHER2-positive Breast CancerGermany, Austria
-
Xijing HospitalNot yet recruitingBreast Cancer | HER2-positive Breast Cancer
-
Breast Cancer Trials, Australia and New ZealandRecruitingBreast Cancer | HER2-positive Breast CancerAustralia
-
Genor Biopharma Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Centre Jean PerrinRecruitingHER2 Positive Breast CancerFrance
-
Shanghai Henlius BiotechActive, not recruitingBreast Cancer | Breast Neoplasms | HER2-positive Breast CancerChina
-
Daiichi SankyoCompletedHER2-positive Breast CancerSpain, Ireland, Italy
-
University of Kansas Medical CenterTerminatedHER2-positive Breast CancerUnited States
-
University of RochesterSuspendedHER2-positive Breast CancerUnited States
-
Armando GiulianoWithdrawnBreast Cancer | HER2-positive Breast CancerUnited States
-
Puma Biotechnology, Inc.CompletedHER2 Amplified Breast CancerPortugal
-
Institut Claudius RegaudTerminated
-
Seagen Inc.ParexelApproved for marketing
-
Henan Cancer HospitalUnknown
-
Hebei Medical University Fourth HospitalUnknown